Cargando…
Can Iron Treatments Aggravate Epistaxis in Some Patients With Hereditary Hemorrhagic Telangiectasia?
OBJECTIVES/HYPOTHESIS: To examine whether there is a rationale for iron treatments precipitating nosebleeds (epistaxis) in a subgroup of patients with hereditary hemorrhagic telangiectasia (HHT). STUDY DESIGN: Survey evaluation of HHT patients, and a randomized control trial in healthy volunteers. M...
Autores principales: | Shovlin, Claire L., Gilson, Clare, Busbridge, Mark, Patel, Dilip, Shi, Chenyang, Dina, Roberto, Abdulla, F. Naziya, Awan, Iman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095791/ https://www.ncbi.nlm.nih.gov/pubmed/27107394 http://dx.doi.org/10.1002/lary.25959 |
Ejemplares similares
-
Renal cell carcinoma presenting as epistaxis from a nasal cavity metastasis
por: Allen, Amanda, et al.
Publicado: (2018) -
Hemorrhage-Adjusted Iron Requirements, Hematinics and Hepcidin Define Hereditary Hemorrhagic Telangiectasia as a Model of Hemorrhagic Iron Deficiency
por: Finnamore, Helen, et al.
Publicado: (2013) -
Circulatory contributors to the phenotype in hereditary hemorrhagic telangiectasia
por: Shovlin, Claire L.
Publicado: (2015) -
Synthetic dural graft septoplasty in epistaxis from hereditary hemorrhagic telangiectasia
por: Burckhardt B, Wilfred, et al.
Publicado: (2013) -
Epistaxis in hereditary hemorrhagic telangiectasia: an evidence based review of surgical management
por: Chin, Christopher J., et al.
Publicado: (2016)